Response to Solicitation of Comments on Professional Organizations and State Governments Requirements for Poison Control Center Certification, 70519-70520 [E6-20564]
Download as PDF
<![CDATA[
70519
Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices
Number of
respondents
Form
Responses
per
respondent
Total
responses
Hours per
response
Total burden
hours
NAT ......................................................................................
100
1
100
1
100
Total ..............................................................................
600
........................
600
........................
600
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to:
John Kraemer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503.
Dated: November 22, 2006.
Caroline Lewis,
Acting, Associate Administrator for
Administration and Financial Management.
[FR Doc. E6–20531 Filed 12–4–06; 8:45 am]
BILLING CODE 4165–15–P
basis for NACNEP’s mandated Seventh
Annual Report.
For Further Information Contact: Anyone
interested in obtaining a roster of members,
minutes of the meeting, or other relevant
information should write or contact Dr. Joan
Weiss, Executive Secretary, National
Advisory Council on Nurse Education and
Practice, Parklawn Building, Room 9–35,
5600 Fishers Lane, Rockville, Maryland
20857, telephone (301) 443–5688.
Dated: November 29, 2006.
Caroline Lewis,
Acting Associate Administrator for
Administration and Financial Management.
[FR Doc. E6–20532 Filed 12–4–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Health Resources and Services
Administration
National Advisory Council on Nurse
Education and Practice; Notice of
Meeting
ycherry on PROD1PC64 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: National Advisory Council on
Nurse Education and Practice (NACNEP).
Dates and Times: December 11, 2006, 9
a.m.–5 p.m. December 12, 2006, 7:30 a.m.–3
p.m.
Place: The Madison Hotel, 1177 15th
Street, NW., Washington, DC 20005.
Status: The meeting will be open to the
public.
Agenda: Agency and Bureau
administrative updates will be provided. The
purpose of the meeting will be to discuss the
role of nursing in developing surge capacity,
with a series of panel discussions relating to
the nursing workforce, integration of health
information technology, providing care to
special populations, and integrating surge
capacity into the nursing curriculum.
Representatives from the Department of
Health and Human Services, Department of
Homeland Security, Centers for Disease
Control and Prevention, Department of
Veteran’s Affairs, American Hospital
Association, INOVA Health Systems, and
American Red Cross will be presenting.
During this meeting, Council workgroups
will deliberate on content presented and
formulate recommendations to the Secretary
of Health and Human Services and the
Congress on role of nursing in developing
surge capacity. This meeting will form the
VerDate Aug<31>2005
15:14 Dec 04, 2006
Jkt 211001
Response to Solicitation of Comments
on Professional Organizations and
State Governments Requirements for
Poison Control Center Certification
A notice was published in the Federal
Register by the Health Resources and
Services Administration (HRSA) on
April 8, 2005 (Volume 70, No. 67 pp.
18036–18037), soliciting public
comment regarding the guidelines by
which the Secretary shall approve
professional organizations and State
governments as having in effect
standards for Poison Control Center
(PCC) certification. Respondents were
asked to submit recommended
guidelines for approving professional
organizations and State governments’
standards per Public Law 108–194
section 1273 (c). Written comments
were to be post marked no later than
June 5, 2005 for consideration.
The HRSA was seeking comment on
the following issues:
1. Modeling the guidelines after
certification requirements that are
currently being used to certify PCCs;
2. Elements of approval that the
guidelines should include and
justification of the elements;
3. Guidelines applying to all State
governments;
4. Guidelines applying to all
professional organizations; and
5. Inclusion or re-certification as an
element of certification.
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
Fifty-two (52) comments were
received. Fifty-one (51) comments were
submitted by poison control centers
(PCCs), 15 of which came from the same
center. All of the poison centers are
members of the American Association of
Poison Control Centers (AAPCC) and
certified by this association. One (1)
comment was also submitted from a
professional organization whose
membership includes staff from poison
control centers. Following is a summary
of the comments received and the
HRSA’s recommendations.
While the HRSA did not receive any
specific comments on the issues
requested in the Federal Register Notice
sited above, 50 comments indicated a
strong advisement for the HRSA to
continue to accept the present
certification process instituted by the
AAPCC as the single certifying body for
poison control centers. These
respondents concurred that the current
certification structure is ‘‘fair, costefficient and already subscribed to by
nearly all of poison centers in the
United States.’’ Additional responses
concluded that resources used to
develop, implement and maintain a new
certification process would be
duplicative and costly. Comments also
suggested that the current certification
process is used as a mechanism to
maintain quality poison prevention
education and treatment services.
The legislation does not call for the
HRSA to change the certification
process, but does require the Secretary
to approve standards for certification.
Therefore, the HRSA was seeking public
comment on what guidelines the HRSA
should use for approving professional
organizations and State governments’
standards for certification.
Of these 50 comments, an additional
response indicated that if a State
certification system were to be
developed it should meet or exceed the
certification criteria established by the
AAPCC. There was one commenter in
support of a State certification process.
This commenter indicated that many
States currently determine the
healthcare standards of their residents
and have the ability to employ
certification standards for PCCs. In this
response, it was also communicated that
a State certification process should be
developed and modeled after the
E:\FR\FM\05DEN1.SGM
05DEN1
70520
Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices
current certification process with the
exception of the requirement ‘‘for nurse/
pharmacist certification through
AAPCC.’’
From the comments received, there is
consensus support for the AAPCC
certification program. The guidelines by
which the Secretary shall approve a
professional organization and/or State
government as having standards for
certification will be that any
certification program must meet or
exceed current certification standards
being used by AAPCC to certify PCCs.
Send comments to Maxine Jones,
HRSA, HSB, Division of Healthcare
Preparedness, Healthcare Systems
Bureau, Room 13–103, 5600 Fishers
Lane, Rockville, MD 20857. Comments
should be received within 60 days of
this notice.
Dated: November 28, 2006.
Elizabeth M. Duke,
Administrator.
[FR Doc. E6–20564 Filed 12–4–06; 8:45 am]
BILLING CODE 4165–15–P
National Institutes of Health
Second Annual Philip S. Chen, Jr.
Distinguished Lecture on Innovation
and Technology Transfer
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The Office of the Director,
NIH, invites you to the second annual
Philip S. Chen, Jr., Ph.D. Distinguished
Lecture on Innovation and Technology
Transfer.
DATES: Friday, January 26, 2007, at 1
p.m.
NIH campus, 9000
Rockville Pike, Bethesda MD, NIH
Clinical Center (Building 10), Lipsett
Auditorium.
ADDRESSES:
For
additional information, sign language
interpretation or accommodation for
disabilities, please contact Colleen
Crone at 301–496–1921 or
cronec@od.nih.gov.
FOR FURTHER INFORMATION CONTACT:
Dr.
Douglas R. Lowy will present ‘‘The
Science, Technology and Promise of
Preventive HPV Vaccines.’’ Dr. Lowy is
Chief of the Basic Research Laboratory
and the Laboratory of Cellular Oncology
at the NCI Center for Cancer Research,
where he also serves as deputy director.
With colleagues at NIH, he developed
ycherry on PROD1PC64 with NOTICES
VerDate Aug<31>2005
15:14 Dec 04, 2006
Jkt 211001
Dated: November 27, 2006.
Bonny Harbinger,
Deputy Director, Office of Technology
Transfer, National Institutes of Health.
[FR Doc. E6–20577 Filed 12–4–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
SUPPLEMENTARY INFORMATION:
the original technology on which the
Merck HPV vaccine, Gardasil, is based.
This annual series honors Dr. Philip
S. Chen, Jr. for his almost 50 years of
service to the National Institutes of
Health. Dr. Chen established NIH’s
Office of Technology Transfer in 1986 to
implement the Federal Technology
Transfer Act. The inventions in the
Office of Technology Transfer’s
intellectual property portfolio are
crucial in advancing the NIH mission—
making important discoveries that
improve health and save lives.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Research in Severe Asthma.
Date: December 12, 2006.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Valerie L. Prenger, PhD,
Health Scientist Administrator, Division of
Extramural Affairs, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, MSC
7924, Room 7214, Bethesda, MD 20892–7924,
(301) 435–0270. prengerv@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: November 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9525 Filed 12–4–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Development of State-of-the-Art Mechanisms
for Epidemiological Research.
Date: December 6, 2006.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Eric Zatman, Contract
Review Specialist, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401, (301) 435–1438.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Develop
a Real-Time fMRI Feedback System that
Allows Drug Abusers to Control Cravings and
Urges and/or Increase Their Self-Control of
Their Drug Taking.
Date: December 20, 2006.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
E:\FR\FM\05DEN1.SGM
05DEN1
]]>Agencies
[Federal Register Volume 71, Number 233 (Tuesday, December 5, 2006)]
[Notices]
[Pages 70519-70520]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20564]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Response to Solicitation of Comments on Professional
Organizations and State Governments Requirements for Poison Control
Center Certification
A notice was published in the Federal Register by the Health
Resources and Services Administration (HRSA) on April 8, 2005 (Volume
70, No. 67 pp. 18036-18037), soliciting public comment regarding the
guidelines by which the Secretary shall approve professional
organizations and State governments as having in effect standards for
Poison Control Center (PCC) certification. Respondents were asked to
submit recommended guidelines for approving professional organizations
and State governments' standards per Public Law 108-194 section 1273
(c). Written comments were to be post marked no later than June 5, 2005
for consideration.
The HRSA was seeking comment on the following issues:
1. Modeling the guidelines after certification requirements that
are currently being used to certify PCCs;
2. Elements of approval that the guidelines should include and
justification of the elements;
3. Guidelines applying to all State governments;
4. Guidelines applying to all professional organizations; and
5. Inclusion or re-certification as an element of certification.
Fifty-two (52) comments were received. Fifty-one (51) comments were
submitted by poison control centers (PCCs), 15 of which came from the
same center. All of the poison centers are members of the American
Association of Poison Control Centers (AAPCC) and certified by this
association. One (1) comment was also submitted from a professional
organization whose membership includes staff from poison control
centers. Following is a summary of the comments received and the HRSA's
recommendations.
While the HRSA did not receive any specific comments on the issues
requested in the Federal Register Notice sited above, 50 comments
indicated a strong advisement for the HRSA to continue to accept the
present certification process instituted by the AAPCC as the single
certifying body for poison control centers. These respondents concurred
that the current certification structure is ``fair, cost-efficient and
already subscribed to by nearly all of poison centers in the United
States.'' Additional responses concluded that resources used to
develop, implement and maintain a new certification process would be
duplicative and costly. Comments also suggested that the current
certification process is used as a mechanism to maintain quality poison
prevention education and treatment services.
The legislation does not call for the HRSA to change the
certification process, but does require the Secretary to approve
standards for certification. Therefore, the HRSA was seeking public
comment on what guidelines the HRSA should use for approving
professional organizations and State governments' standards for
certification.
Of these 50 comments, an additional response indicated that if a
State certification system were to be developed it should meet or
exceed the certification criteria established by the AAPCC. There was
one commenter in support of a State certification process. This
commenter indicated that many States currently determine the healthcare
standards of their residents and have the ability to employ
certification standards for PCCs. In this response, it was also
communicated that a State certification process should be developed and
modeled after the
[[Page 70520]]
current certification process with the exception of the requirement
``for nurse/pharmacist certification through AAPCC.''
From the comments received, there is consensus support for the
AAPCC certification program. The guidelines by which the Secretary
shall approve a professional organization and/or State government as
having standards for certification will be that any certification
program must meet or exceed current certification standards being used
by AAPCC to certify PCCs.
Send comments to Maxine Jones, HRSA, HSB, Division of Healthcare
Preparedness, Healthcare Systems Bureau, Room 13-103, 5600 Fishers
Lane, Rockville, MD 20857. Comments should be received within 60 days
of this notice.
Dated: November 28, 2006.
Elizabeth M. Duke,
Administrator.
[FR Doc. E6-20564 Filed 12-4-06; 8:45 am]
BILLING CODE 4165-15-P
